tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Income Statement

Compare
445 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q3 2024), Kiniksa Pharmaceuticals's total revenue was $112.21M, an increase of 67.37% from the same quarter last year. In Q3, Kiniksa Pharmaceuticals's net income was $-12.69M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 270.26M$ 220.18M$ 38.54M$ 0.00$ 0.00
Gross Profit
$ 213.74M$ 173.21M$ 29.44M$ -3.81M$ -3.28M
Operating Expenses
$ 238.93M$ 163.44M$ 186.08M$ 157.36M$ 169.96M
Depreciation and Amortization
$ 2.34M$ 4.22M$ 4.09M$ 3.81M$ 3.28M
EBITDA
$ -22.86M$ 9.77M$ -154.28M$ -152.42M$ -167.90M
Operating Income
$ -25.20M$ 7.37M$ -156.64M$ -157.36M$ -169.96M
Other Income/Expenses
$ 8.54M$ 1.25M$ 97.00K$ 1.13M$ 6.05M
Pretax Income
$ -16.65M$ 11.03M$ -156.54M$ -156.23M$ -163.91M
Net Income
$ 14.08M$ 183.36M$ -157.92M$ -161.38M$ -161.87M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.20$ 2.64$ -2.30$ -2.61$ -2.99
Diluted EPS
$ 0.20$ 2.60$ -2.30$ -2.61$ -2.99
Weighted Average Shares Outstanding
70.06M 69.38M 68.58M 61.84M 54.05M
Weighted Average Shares Outstanding (Diluted)
71.92M 70.42M 68.58M 61.84M 54.05M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis